Glax­oSmithK­line in­vests in the UK

China Daily (Canada) - - BUSINESS -

Glax­oSmithK­line Plc plans 275 mil­lion pounds ($361 mil­lion) of new in­vest­ments at three drug man­u­fac­tur­ing sites in the United King­dom, sig­nal­ing its con­fi­dence in the coun­try de­spite last month’s vote to leave the Euro­pean Union. Bri­tain has “com­pet­i­tive cor­po­rate tax sys­tem’’ and skilled work­force, GSK CEO An­drew Witty said.

Newspapers in English

Newspapers from China

© PressReader. All rights reserved.